drugs

Roche Boosted By Cancer drugs, Emerging Markets - Wall Street Journal
stv.tvRoche Boosted By Cancer drugs, Emerging MarketsWall Street JournalThe company's plan to file its breast cancer drug T-DM1 for regulatory approval in the US after successful phase II trials also lifted investor sentiment, ...Cancer drugs, emerging markets boost Roche salesFiercePharmaRoche Keeps Its PromisesWall Street Journal (blog)Roche sales up 6 percent on cancer drugs, top forecastsReutersSan Francisco Chronicle�-Seattle Times�-CNBCall 185 news articles��

Blog Content